Graphene Oxide Doped Conducting Polymer for Bioagent Immobilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conducting polymers like PEDOT lack functional groups for immobilizing biologically active agents, leading to electronic and steric limitations, and existing methods for adding these groups are either complex or impair conductivity and stability.
Innovation Solution
A composite material is created by doping conducting polymers with graphene oxide, allowing biologically active agents to be immobilized on or within the graphene oxide, which extends from the surface or is embedded within the composite, enabling controlled release through electrical stimulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If functional groups are added to conducting polymers through direct addition to monomers, then the ability to immobilize biologically active agents is improved, but the synthesis complexity and purification procedures increase
Solution Approach 1:
The patent segments the functional group addition process from the polymerization process. Instead of adding functional groups to monomers before polymerization, the patent uses graphene oxide as a separate component that provides functional groups after polymerization. This segmentation eliminates the need for complex monomer synthesis and purification while maintaining the ability to immobilize biologically active agents on the functional groups of graphene oxide.
Solution Approach 2:
Graphene oxide serves as an intermediary that bridges the conducting polymer and biologically active agents. The graphene oxide provides functional groups (carboxyl, hydroxyl, epoxy) that can immobilize biomolecules, while the conducting polymer provides electrical conductivity. This intermediary approach avoids direct modification of the polymer monomers and simplifies the overall synthesis process.
2Adaptability or versatility
If functional groups are added through copolymerization, then the ability to immobilize biologically active agents is improved, but the conductivity and stability of the polymer are impaired
Solution Approach 1:
The patent merges three components into a composite material: conducting polymer, graphene oxide, and biologically active agents. The conducting polymer maintains its conductivity and stability, while graphene oxide provides functional groups for immobilization. This merging approach allows each component to retain its optimal properties while contributing to the overall functionality of the system.
Solution Approach 2:
The patent creates a composite material consisting of conducting polymer and graphene oxide. This composite structure allows the conducting polymer to maintain its electrical properties while graphene oxide provides surface functional groups for biomolecule immobilization. The composite approach resolves the contradiction by combining materials with complementary properties rather than modifying a single material.
3Adaptability or versatility
If biomolecules are used as dopants, then the bioactive functionality is improved, but the conductivity and stability are reduced due to weak charge and large size
Solution Approach 1:
The patent extracts the doping function from the biomolecules themselves and assigns it to graphene oxide. Instead of using biomolecules as dopants (which have weak charge and large size), the patent uses graphene oxide as the dopant that provides strong negative charges. This allows biomolecules to be immobilized on the graphene oxide surface without compromising the electrical doping of the conducting polymer.
Solution Approach 2:
Graphene oxide acts as an intermediary between the conducting polymer and biomolecules. It serves as the actual dopant that provides negative charges to the polymer, while biomolecules are immobilized on the graphene oxide surface through functional groups. This intermediary role resolves the contradiction by separating the doping function from the biomolecules.
4Adaptability or versatility
If biomolecules are entrapped throughout the film, then the bioactive functionality is improved, but the exposure of functional domains at the surface is limited
Solution Approach 1:
The patent concentrates biomolecules at the surface of the composite material rather than distributing them throughout the bulk. Graphene oxide sheets with immobilized biomolecules are positioned at the surface, creating a functionalized interface with high surface exposure. This local concentration of functionality at the surface maximizes the area available for biological interactions while maintaining the bulk properties of the conducting polymer.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The graphene oxide-doped conducting polymer composite materials demonstrate biocompatibility, enhanced electrical properties, and controlled release of bioactive agents, supporting neuronal growth and maturation while maintaining conductivity and stability.
Implementation Method 1
A composite material is created by doping conducting polymers with graphene oxide
Implementation Method 2
The at least one agent may, for example, be chemically bonded to the graphene oxide or adsorbed on the graphene oxide
Implementation Method 3
The at least one agent may, for example, be chemically bonded to the graphene oxide or adsorbed on the graphene oxide
Implementation Method 4
The at least one agent may, for example, be controllably released from within the composition via application of electrical energy thereto
Data Source
AI summary
A composition includes at least one polymer doped with graphene oxide to induce conductivity in the polymer and at least one agent immobilized at least one of (i) on graphene oxide extending from the surface of the composite material or (ii) within the composite material.